TenX Investment

Home › Funds › Equity index funds › Tata Nifty MidSmall Healthcare Index Fund

Index · Equity · Tata

Tata Nifty MidSmall Healthcare Index Fund

NAV, returns, holdings and category rank. Updated 6 Nov 2026.

Tata Nifty MidSmall Healthcare Index Fund is an Equity index fund from Tata. Over the last year it returned +19.6%. Its largest holdings are Laurus Labs Ltd, Lupin Ltd, Aurobindo Pharma Ltd.

Invest in this fundLump sum or monthly SIP in the regular plan, placed on NSE MF Invest. You confirm with an OTP and pay NSE Clearing directly.

At a glance

What it holds

30
  • Pharmaceuticals & Biotechnology 80%
  • Healthcare Services 19%
  • Healthcare Equipment & Supplies 1%

100% in shares across 30 stocks. Biggest: Laurus Labs Ltd, Lupin Ltd, Aurobindo Pharma Ltd.

Last five years

How bumpy

Worst fall in five years

In past market falls

From AMFI NAV history (via mfapi.in) and NSE's Nifty 50 month-end levels, price only. Past performance may or may not be sustained in future. A description of the past, not a rating or a recommendation.

PlanNAV1 year3 years a yr5 years a yr3Y rank
Regular₹15.3476+19.58%———
Direct₹15.6012+20.31%———

1-year figures are absolute returns; 3 and 5-year figures are yearly compounded. Growth options, from AMFI's NAVs. Ranks compare the same plan within the category by past return; they are not a rating.

What Tata Nifty MidSmall Healthcare Index Fund owns

30 stocks, 100.1% of the fund in shares, from the portfolio Tata disclosed for September 2026.

Top 10 holdings

Laurus Labs LtdPharmaceuticals & Biotechnology11.84%
Lupin LtdPharmaceuticals & Biotechnology7.57%
Aurobindo Pharma LtdPharmaceuticals & Biotechnology7.09%
Fortis Healthcare LtdHealthcare Services6.16%
Glenmark Pharmaceuticals LtdPharmaceuticals & Biotechnology5.40%
Alkem Laboratories LtdPharmaceuticals & Biotechnology4.78%
Mankind Pharma LtdPharmaceuticals & Biotechnology4.36%
IPCA Laboratories LtdPharmaceuticals & Biotechnology4.11%
Biocon LtdPharmaceuticals & Biotechnology3.96%
Gland Pharma LtdPharmaceuticals & Biotechnology3.55%

Sector mix

Pharmaceuticals & Biotechnology79.9%
Healthcare Services19.3%
Healthcare Equipment & Supplies1.0%

Other Equity index funds

See all 362 Equity index funds ranked

Questions

What is the NAV of Tata Nifty MidSmall Healthcare Index Fund?

The regular plan's NAV was ₹15.3476 on 6 Nov 2026. The direct plan's NAV was ₹15.6012 on 6 Nov 2026.

What returns has Tata Nifty MidSmall Healthcare Index Fund given?

Regular plan: +19.6% over 1 year, — a year over 3 years and — a year over 5 years, as of 6 Nov 2026. Past performance may or may not be sustained in future.

Which stocks does Tata Nifty MidSmall Healthcare Index Fund hold?

As disclosed for September 2026, its top holdings were Laurus Labs Ltd, Lupin Ltd, Aurobindo Pharma Ltd, out of 30 stocks.

Should I choose the regular or the direct plan?

Both plans hold the same portfolio. The direct plan has a lower expense ratio; the regular plan is bought through a distributor, who is paid a commission and helps you choose, invest and keep track.